Osaic Holdings’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,689
Closed -$113K 7602
2023
Q2
$113K Sell
2,689
-20,175
-88% -$816K ﹤0.01% 4344
2023
Q1
$816K Buy
22,864
+2,335
+11% +$84.7K ﹤0.01% 2671
2022
Q4
$753K Sell
20,529
-7,124
-26% -$282K ﹤0.01% 2646
2022
Q3
$1.3M Sell
27,653
-304
-1% -$19.6K ﹤0.01% 1971
2022
Q2
$2M Buy
27,957
+1,899
+7% +$139K ﹤0.01% 1668
2022
Q1
$2.58M Sell
26,058
-1,914
-7% -$162K 0.01% 1721
2021
Q4
$2.87M Buy
27,972
+133
+0.5% +$12.8K 0.01% 1481
2021
Q3
$2.43M Buy
27,839
+7,805
+39% +$706K 0.01% 1541
2021
Q2
$1.79M Buy
20,034
+2,169
+12% +$183K ﹤0.01% 1815
2021
Q1
$1.35M Buy
17,865
+7,169
+67% +$540K ﹤0.01% 1956
2020
Q4
$728K Buy
10,696
+226
+2% +$14.1K ﹤0.01% 2315
2020
Q3
$559K Buy
10,470
+1,159
+12% +$69K ﹤0.01% 2331
2020
Q2
$542K Buy
9,311
+1,044
+13% +$56.1K ﹤0.01% 2277
2020
Q1
$325K Buy
+8,267
New +$483K ﹤0.01% 2459

Other funds holding SYNH

Osaic Holdings's SYNH Position: Q3 2023 in Review

Osaic Holdings sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 2,689 shares — an estimated $113K sold.

Osaic Holdings first reported a position in SYNH in Q1 2020 and held it in 14 quarters. The position peaked at $2.87M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Osaic Holdings reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 2,689 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $113K.
  • Osaic Holdings first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2020 and held it in 14 quarters.
  • Osaic Holdings's Syneos Health, Inc. Class A Common Stock position peaked at $2.87M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.